tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adicet Bio Reports Promising Phase 1 Study Results
PremiumCompany AnnouncementsAdicet Bio Reports Promising Phase 1 Study Results
7d ago
Adicet Bio’s ADI-001 shows positive preliminary Phase 1 results in LN and SLE
Premium
The Fly
Adicet Bio’s ADI-001 shows positive preliminary Phase 1 results in LN and SLE
7d ago
Adicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
Premium
Ratings
Adicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
13d ago
Promising Pipeline and FDA Fast Track Designations Justify Buy Rating for Adicet Bio
PremiumRatingsPromising Pipeline and FDA Fast Track Designations Justify Buy Rating for Adicet Bio
3M ago
Adicet Bio doses first patient in second cohort of ADI-001 trial
Premium
The Fly
Adicet Bio doses first patient in second cohort of ADI-001 trial
3M ago
Adicet Bio Announces 30% Workforce Reduction Strategy
Premium
Company Announcements
Adicet Bio Announces 30% Workforce Reduction Strategy
3M ago
Adicet Bio’s Innovative Cell Therapy Programs and Strategic Focus Highlight Promising Growth Potential
PremiumRatingsAdicet Bio’s Innovative Cell Therapy Programs and Strategic Focus Highlight Promising Growth Potential
5M ago
Adicet Bio’s Promising Pipeline and Strategic Developments Earn Buy Rating
Premium
Ratings
Adicet Bio’s Promising Pipeline and Strategic Developments Earn Buy Rating
5M ago
Adicet Bio Reports Q1 2025 Results and Updates
Premium
Company Announcements
Adicet Bio Reports Q1 2025 Results and Updates
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100